Karakolevska Ilova, Marija (2012) Ewing sarcoma. In: Soft Tissue, Bone, and Skin Malignancies, 02-08.12.2012, Salzburg,Austria. (Unpublished)
![]() |
Slideshow
Ewing sarcoma - case report.mk.ppt Download (1MB) |
Abstract
Patients with metastases and recurrent disease still fare poorly, with 5-year survival rates of 20% witch highlights the need for novel chemotherapeutic agents, bisphosphonates and targeted therapy.Ewing's sarcoma has a propensity to metastasize to the lung, bone and bone marrow. This tumor can also involve the CNS with a relatively low incidence – 1-8%.
Prognostic factors that confer poorer outcome are: serum LDH level, axial localization or older age ( > 15 years), size and volume, incomplete or no surgery for local therapy and time of relaps ( < 24 months ).
This is a case report that brings out all of bad prognostic factors associated with disease free survivel and overoll survival.
Item Type: | Conference or Workshop Item (Speech) |
---|---|
Subjects: | Medical and Health Sciences > Clinical medicine |
Divisions: | Faculty of Medical Science |
Depositing User: | Marija Karakolevska |
Date Deposited: | 10 Dec 2012 16:32 |
Last Modified: | 10 Dec 2012 16:32 |
URI: | https://eprints.ugd.edu.mk/id/eprint/3284 |
Actions (login required)
![]() |
View Item |